Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Active not recruiting 1

Sponsor Class

OTHER 4NETWORK 4NIH 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Uterine Cervical Neoplasms 4Neoplasms 3Prostatic Neoplasms 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Endometrial Neoplasms 2Uterine Neoplasms 1Sarcoma 1Lung Neoplasms 1Locally Advanced Cervical Cancer 1Carcinoma 1Breast Neoplasms 1Adenocarcinoma 1

Interventions

Doxorubicin 33pembrolizumab 16Gemcitabine 15eribulin 10Irinotecan 10olaratumab 9Trabectedin 9pazopanib 8Docetaxel 8Injections 7Cyclophosphamide 7Nivolumab 6Fluorouracil 6anlotinib 5Temozolomide 5Ipilimumab 5Ifosfamide 5Bevacizumab 5tazemetostat 4ridaforolimus 4Drug Therapy 4Cetuximab 4Carboplatin 4toripalimab 3surufatinib 3spartalizumab 3ganitumab 3entrectinib 3conatumumab 3belinostat 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Sarcoma × Brachytherapy × Clear all
NCT04033081 2026-03-23

Registry of Sarcoma Patients Treated With Permanently Implantable LDR CivaSheet®

CivaTech Oncology

Phase 4 Active not recruiting
100 enrolled
Sarcoma

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡